Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 44 (96th)

Prescription Drug Labeling Act

referredUnited States· United States Congress· EN

Introduced

15 January 1979

Last action

15 January 1979 · Introduced

Status

Referred to House Committee on Interstate and Foreign Commerce.

Sponsors

Rep. Rosenthal, Benjamin S. [D-NY-8], Rep. Bedell, Berkley W. [D-IA-6], Rep. Blanchard, James [D-MI-18], Rep. Bingham, Jonathan B. [D-NY-22], Rep. Bonior, David E. [D-MI-10], Rep. Brodhead, William [D-MI-17], Rep. Burton, Phillip [D-CA-6], Rep. Carr, Bob [D-MI-8], Rep. Corcoran, Tom [R-IL-14], Rescom. Corrada, Baltasar [I-PR-At Large], Rep. Corman, James C. [D-CA-21], Rep. Dornan, Robert K. [R-CA-46], Rep. Edwards, Don [D-CA-10], Rep. Ferraro, Geraldine A. [D-NY-9], Rep. Leland, Mickey [D-TX-18], Rep. McCloskey, Paul N., Jr. [R-CA-12], Rep. McCormack, Mike [D-WA-4], Rep. Moakley, John Joseph [D-MA-9], Rep. Mottl, Ronald M. [D-OH-23], Rep. Price, Melvin [D-IL-21], Rep. Rangel, Charles B. [D-NY-15], Rep. Rodino, Peter W., Jr. [D-NJ-10], Rep. Scheuer, James H. [D-NY-8], Rep. Stark, Fortney Pete [D-CA-13], Rep. Vento, Bruce F. [D-MN-4], Rep. Weaver, James H. [D-OR-4], Rep. Weiss, Ted [D-NY-17], Rep. Zeferetti, Leo C. [D-NY-15], Rep. Waxman, Henry A. [D-CA-33], Rep. Anderson, Glenn M. [D-CA-32], Rep. Long, Clarence D. [D-MD-2]

Subjects

Healthcare

Source updated

2 September 2025

Healthcare

Official sourceView documentsShare

Summary

Prescription Drug Labeling Act - Amends the Federal Food, Drug, and Cosmetic Act to require that in the labeling and advertising of drugs sold by prescription the established name of such drug must appear each time the drug's proprietary name is used. Allows a pharmacist to fill or refill a prescription for a drug identified by its proprietary name with a substitute drug of the same established name or the same qualitative composition, unless the prescription requires the proprietary name drug exclusively. Requires that such substitute drugs, whether identified in the prescription by proprietary or by established name, be sold at a cost to the patient which is less than the cost of the drug so identified.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 15 January 1979

    Introduced

    Referred to House Committee on Interstate and Foreign Commerce.

    Source: IntroReferral

  2. 15 January 1979

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 15 January 1979

    Introduced

    Introduced in House

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.